SCHEMBL3972226

SCHEMBL3972226

[CH2]CCCCC(Br)(Br)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL960249 0.97
SCHEMBL9015693 0.97
SCHEMBL20267650 0.97
SCHEMBL962288 0.90
SCHEMBL11048283 0.78 ALDH1A1 (0.36)
SCHEMBL31398004 0.78 ALDH1A1 (0.36)
SCHEMBL14763204 0.75
SCHEMBL959282 0.74
SCHEMBL2136 0.68
SCHEMBL246505 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240065265-A1 METHODS FOR CONTROL OF PESTS BIO-GENE TECHNOLOGY LIMITED (AU) 2024-02-29 US disclosed
WO-2023245257-A1 IMPROVED PESTICIDAL COMPOSITIONS AND PEST CONTROL METHODS BIO-GENE TECHNOLOGY LIMITED (AU) 2023-12-28 WO disclosed
US-11800866-B2 Methods for control of pests Bio-Gene Technology Unlimited (AU) 2023-10-31 US disclosed
US-20230292751-A1 CONTROL OF RESISTANT PESTS BIO-GENE TECHNOLOGY LIMITED (AU) 2023-09-21 US disclosed
US-11712039-B2 Control of resistant pests BIO-GENE TECHNOLOGY LIMITED (AU) 2023-08-01 US disclosed
US-11259522-B2 Control of resistant pests BIO-GENE TECHNOLOGY LIMITED (AU) 2022-03-01 US disclosed
US-20210076675-A1 PEST MANAGEMENT BIO GENE TECH LIMITED (AU) 2021-03-18 US disclosed
US-20210051951-A1 CONTROL OF RESISTANT PESTS BIO-GENE TECHNOLOGY LIMITED (AU) 2021-02-25 US disclosed
US-20210051952-A1 METHODS FOR CONTROL OF PESTS BIO-GENE TECHNOLOGY LIMITED (AU) 2021-02-25 US disclosed
EP-3772951-A1 METHODS FOR CONTROL OF PESTS Bio-Gene Technology Limited (AU) 2021-02-17 EP disclosed
EP-1562074-A1 Imaging compositions and methods Rohm and Haas Electronic Materials, L.L.C. (US) 2005-08-10 EP disclosed
US-20050020667-A1 Compounds and therapies for the prevention of vascular and non-vascular pathologies PONIARD PHARMACEUTICALS, INC. 2005-01-27 US disclosed
US-6734208-B2 ADJUSTMENT TRANSFORMING GROWTH FACTOR CONCENTRATION; ANTIINFLAMMATORY AGENTS NEORX CORPORATION 2004-05-11 US disclosed
US-20030064970-A1 Compounds and therapies for the prevention of vascular and non-vascular pathologies NEORX CORPORATION 2003-04-03 US disclosed
US-6410587-B1 FIBROSIS; ALZHEIMER'S DISEASE; ANTIARTHRITIC AGENTS NEORX CORPORATION 2002-06-25 US disclosed
US-6117911-A ADMINISTRATION OF AT LEAST ONE THERAPEUTIC AGENT THAT ELEVATES THE LEVEL OF TGF-BETA IN SAID MAMMAL. NEORX CORPORATION (US) 2000-09-12 US disclosed
WO-1998046588-A2 COMPOUNDS AND THERAPIES FOR THE PREVENTION OF VASCULAR AND NON-VASCULAR PATHOLOGIES NEORX CORPORATION (US) 1998-10-22 WO disclosed
US-5401608-A Hydroxy-styrene and melamine derivative polymers HOECHST AKTIENGESELLSCHAFT (DE) 1995-03-28 US disclosed
US-5302711-A Ester cleavage process for use with β-lactams ELI LILLY AND COMPANY (US) 1994-04-12 US disclosed
EP-0557035-A2 An ester cleavage process for use with beta-lactams ELI LILLY AND COMPANY (US) 1993-08-25 EP disclosed